1. Introduction to Intermittent Fasting in Surgical Context

Intermittent fasting (IF) is a dietary pattern that cycles between periods of fasting and eating. It is not primarily about what to eat, but rather when to eat. Common protocols include the 16:8 method (fasting for 16 hours, eating within an 8-hour window) and alternate-day fasting. In the context of surgery, the focus shifts from long-term metabolic health to a specific, short-term application: potentially preparing the body for the physiological stress of an operation and enhancing recovery.

The theoretical rationale for applying IF before surgery is rooted in its documented effects on fundamental cellular and metabolic processes. Preclinical and some human studies suggest that periods of fasting can trigger adaptive cellular responses, including:

Autophagy: A cellular "clean-up" process where damaged components are recycled, which may improve cellular resilience.
Metabolic Switching: Shifting the body's primary fuel source from glucose to ketones and fatty acids, which may reduce oxidative stress and inflammation.
Insulin Sensitivity: Improved insulin sensitivity can lead to better glycemic control, a critical factor in postoperative recovery, especially for patients with diabetes or metabolic syndrome.

It is crucial to distinguish between the strong evidence for IF's benefits in certain metabolic conditions and the more preliminary, evolving evidence for its role in surgical care. While the mechanistic underpinnings are promising, clinical translation to surgical outcomes requires careful scrutiny. Current research is exploring whether these adaptations can translate into tangible benefits such as reduced postoperative complications, less surgical site infection, shorter hospital stays, and improved pain management.

Clinical Perspective: In surgical practice, the concept of preoperative fasting is not new; patients are traditionally instructed to abstain from food and fluids for 8-12 hours before anesthesia to prevent aspiration. The novel inquiry is whether a structured, longer-term fasting protocol initiated days or weeks before surgery—distinct from the standard NPO (nil per os) order—confers an additional therapeutic advantage. This represents a significant paradigm shift from viewing fasting merely as a safety precaution to potentially leveraging it as a proactive therapeutic intervention.

This chapter introduces the key concepts and biological rationale. It is essential to note that IF is not appropriate for all surgical candidates. Individuals who should exercise extreme caution or avoid preoperative fasting protocols without direct medical supervision include:

Those with a history of eating disorders.
Patients who are underweight, malnourished, or have significant muscle wasting (sarcopenia).
Individuals with certain metabolic disorders, advanced kidney or liver disease.
Pregnant or breastfeeding women.

Anyone considering IF in relation to an upcoming surgery must consult their surgical team and a registered dietitian or relevant specialist to assess individual risks and benefits.

2. Mechanisms and Evidence from Clinical Research

The theoretical rationale for using intermittent fasting (IF) to enhance surgical outcomes is grounded in its ability to induce a controlled metabolic stress response. This response, primarily through the activation of cellular pathways like autophagy and the upregulation of stress-resistance proteins, is hypothesized to improve physiological resilience. The proposed mechanisms include:

Enhanced Metabolic Flexibility: Fasting periods may improve the body's ability to switch between fuel sources, potentially preserving lean muscle mass and glycogen stores during the catabolic stress of surgery.
Reduction of Systemic Inflammation: Some preclinical and human studies suggest IF can lower baseline levels of pro-inflammatory cytokines, which could theoretically mitigate the inflammatory surge post-operatively.
Activation of Cellular Repair: The induction of autophagy—the body's process of clearing out damaged cellular components—is a key proposed benefit, potentially leading to more efficient healing and recovery.

However, the translation of these mechanisms into tangible clinical benefits for surgical patients requires careful scrutiny of the available evidence.

Expert Insight: While the mechanistic science is compelling in animal models, human surgical populations are far more heterogeneous. The timing, duration, and type of fasting protocol are critical variables. A short-term pre-operative fast may not be sufficient to trigger the beneficial pathways seen in long-term IF regimens, and the risk of exacerbating malnutrition in at-risk patients is a significant clinical concern.

Clinical research in this area is nascent and characterized by small-scale trials and observational studies. Some pilot studies in specific surgical contexts, such as bariatric or orthopedic surgery, have reported trends toward:

Reduced post-operative insulin resistance.
Modest improvements in subjective recovery metrics.
Better preservation of muscle function.

These findings are preliminary. Robust, large-scale randomized controlled trials (RCTs) with hard clinical endpoints—such as major complication rates, length of hospital stay, or long-term functional recovery—are largely lacking. The evidence is currently stronger for the mechanistic plausibility than for proven, widespread clinical efficacy.

Who should be cautious? Individuals with specific medical conditions must avoid self-initiating pre-surgical fasting protocols without direct medical supervision. This includes patients with:

Diabetes or hypoglycemia risk
History of eating disorders
Chronic kidney disease
Advanced liver disease
Existing malnutrition or cachexia

Any consideration of IF in a surgical context should be a shared decision-making process with the surgical and anesthesiology team, as it must be carefully integrated with standard pre-operative instructions, including nil-by-mouth guidelines.

3. Risks, Contraindications, and Populations to Avoid

While preoperative fasting is a standard surgical protocol, the intentional, longer-term practice of intermittent fasting (IF) for surgical enhancement is not without risk. The evidence for its benefits is preliminary, primarily from animal studies and small human trials. The potential harms, however, are well-documented in specific populations and must be carefully weighed.

Absolute and Relative Contraindications

Certain individuals should avoid therapeutic intermittent fasting unless under direct, continuous medical supervision. The risks significantly outweigh any theoretical benefits in these groups:

Individuals with a history of eating disorders: IF can trigger or exacerbate disordered eating patterns, including anorexia nervosa, bulimia, or binge-eating disorder.
Patients with type 1 diabetes or advanced type 2 diabetes on insulin/sulfonylureas: The risk of severe hypoglycemia is substantial and can be life-threatening.
Pregnant or lactating individuals: Caloric and nutrient restriction is contraindicated, as it can impair fetal development and milk production.
Children and adolescents: Their high nutritional demands for growth and development make fasting regimens inappropriate.

Populations Requiring Extreme Caution

For others, IF may pose significant risks that could negatively impact surgical readiness and recovery. A thorough pre-operative assessment is essential for:

Patients with chronic kidney disease (CKD): Fasting can alter electrolyte balance and increase uremic toxin load, potentially worsening renal function.
Individuals with a history of significant cardiovascular disease: While some studies suggest metabolic benefits, the stress of fasting could theoretically provoke arrhythmias or hypotension in unstable patients.
Those with advanced liver disease: Impaired glycogen storage and gluconeogenesis can lead to dangerous hypoglycemia.
Patients on multiple medications (polypharmacy): Fasting can dramatically alter drug absorption and metabolism, especially for medications that must be taken with food.
Underweight individuals or those with sarcopenia: Further caloric restriction can lead to catastrophic loss of lean muscle mass, impairing wound healing and recovery.

Clinical Perspective: The decision to use IF preoperatively is not a patient-led lifestyle choice but a potential medical intervention. It requires a comprehensive evaluation of nutritional status, comorbidities, and medication lists. For most elective surgery patients, the priority is achieving adequate protein and micronutrient intake to support anabolism and immune function, not inducing a fasted state beyond standard NPO (nil per os) guidelines. Any discussion of IF should be initiated and monitored by the surgical and anesthesia team.

In summary, the populations for whom intermittent fasting might be safely considered to potentially improve surgical outcomes are narrow—likely limited to metabolically healthy, non-underweight individuals without the contraindications listed above. For all others, the risks are clear and clinically significant. Any patient considering this approach must consult their surgeon and a registered dietitian well in advance of their procedure.

4. Practical Implications and Evidence-Based Takeaways

The current body of research on intermittent fasting (IF) and surgical outcomes is promising but preliminary. The strongest evidence, primarily from animal models and some human pilot studies, points toward potential benefits in reducing surgical stress and enhancing recovery. However, translating these findings into universal clinical practice requires caution and individualization.

Key Evidence-Based Takeaways

Based on the available literature, the most consistent potential benefits of a structured pre-operative fasting protocol include:

Reduced Inflammation: Pre-operative IF may help modulate the body's inflammatory response, potentially leading to less post-operative swelling and pain.
Metabolic Flexibility: By encouraging the body to utilize fat stores for energy, IF might improve metabolic resilience during the catabolic stress of surgery.
Enhanced Cellular Repair: The process of autophagy, triggered by fasting, could support cellular cleanup and repair mechanisms post-surgery.

It is crucial to note that much of the human data comes from small-scale studies or specific surgical contexts (e.g., bariatric, cardiac). Large-scale, randomized controlled trials with diverse patient populations are needed to confirm efficacy and establish optimal protocols.

Clinical Perspective: In practice, the consideration of pre-operative IF is not about extreme calorie restriction but about timing nutrient intake to leverage metabolic pathways. The focus is shifting from just "NPO after midnight" to more nuanced, "pre-habilitation" strategies that may include shortened, specific fasting windows tailored to the patient and procedure.

Who Should Exercise Caution?

Intermittent fasting is not appropriate for all surgical candidates. Individuals should consult their surgical and anesthesia team before considering any alteration to standard pre-operative instructions, especially if they have:

Diabetes or blood sugar dysregulation
A history of eating disorders
Chronic kidney disease
Conditions causing malnutrition or cachexia
Pregnancy

The primary practical implication is that IF should not be self-prescribed before surgery. Any fasting protocol must be integrated into a comprehensive pre-surgical plan developed with healthcare providers, considering the type of surgery, anesthesia plan, and the patient's complete medical history. The goal is to support recovery without compromising safety or nutritional status.

5. Safety Protocols and Indications for Medical Consultation

While the potential benefits of intermittent fasting (IF) in a surgical context are an active area of research, its implementation must be guided by stringent safety protocols. The evidence for pre-operative fasting is robust and standardised, whereas the data on longer-term IF protocols for enhancing recovery is more preliminary. Any deviation from standard pre-operative instructions should only occur under direct medical supervision.

Essential Pre-Operative Safety Protocols

Standard nil-by-mouth (NPO) guidelines exist to prevent pulmonary aspiration during anesthesia. These protocols are non-negotiable for patient safety. Research into IF should not be conflated with these mandatory fasting periods. If a clinical trial or a surgeon recommends a specific IF regimen prior to surgery, it must be:

Explicitly prescribed with clear start and stop times.
Integrated with standard NPO orders, not replacing them.
Monitored for adherence and any adverse effects like dizziness, hypoglycemia, or excessive weakness.

Clinical Insight: From a surgical safety perspective, the primary concern is nutritional status and metabolic reserve. An inappropriate or overly aggressive fasting protocol can lead to catabolism, impair wound healing, and increase surgical risk. The decision to use IF must be individualized, weighing potential theoretical benefits against the concrete need for adequate protein and energy for recovery.

Key Indications for Mandatory Medical Consultation

Patients should not initiate any form of intermittent fasting before or after surgery without first consulting their surgical team and, often, a registered dietitian. This is absolutely critical for individuals with pre-existing conditions, including:

Diabetes (type 1 or type 2), due to high risk of hypoglycemia and medication interactions.
History of eating disorders or significant, unintentional weight loss.
Chronic kidney or liver disease.
Conditions affecting nutrient absorption (e.g., IBD, prior bariatric surgery).
Patients on multiple medications, especially diuretics, antihypertensives, or anticoagulants, where fasting can alter drug metabolism or electrolyte balance.
Elderly patients or those with low body mass index (BMI), who have less metabolic reserve.

The current evidence is insufficient to support IF as a standard, unsupervised pre-habilitation strategy. A responsible approach involves a thorough medical evaluation to identify contraindications and a structured, monitored plan if IF is deemed appropriate within a research or very specific clinical context.

6. Questions & Expert Insights

Does intermittent fasting improve wound healing and recovery after surgery?

The evidence is preliminary and largely from animal studies. Research suggests that fasting may trigger cellular repair processes like autophagy and reduce systemic inflammation, which could theoretically create a more favorable environment for healing. However, human clinical trials in surgical patients are extremely limited. Most evidence comes from studies on metabolic health, not direct surgical recovery. The stress of surgery itself creates significant metabolic demands for protein and energy to repair tissues. Therefore, prolonged fasting immediately before or after an operation is not supported by evidence and could be counterproductive by impairing the body's ability to synthesize new proteins and mount an effective immune response. Any potential benefit would likely depend on the specific fasting protocol, the type of surgery, and the patient's overall nutritional status.

Expert Insight: Surgeons prioritize "anabolic readiness" for recovery. This means ensuring a patient has adequate protein and calorie reserves to heal. While preclinical data on fasting and reduced inflammation is intriguing, the jump to recommending it for post-surgical healing in humans is premature. Our current standard of care focuses on prehabilitation (optimizing nutrition before surgery) and avoiding significant catabolism (tissue breakdown) afterward.

What are the main risks, and who should absolutely avoid fasting before surgery?

Intermittent fasting poses significant risks for several patient groups and can interfere with standard surgical protocols. Key risks include hypoglycemia (dangerously low blood sugar), dehydration, electrolyte imbalances, and increased catabolism (muscle breakdown). Individuals who should avoid fasting before surgery include: those with diabetes or blood sugar dysregulation; patients with a low Body Mass Index (BMI) or a history of malnutrition, eating disorders, or sarcopenia (age-related muscle loss); individuals with chronic kidney disease; and those on medications that require food intake (e.g., certain pain medications, NSAIDs, or drugs with gastrointestinal side effects). Furthermore, anesthesiologists require strict guidelines on fasting from solids and liquids to prevent pulmonary aspiration during surgery; any additional fasting outside these protocols is not advised.

If I'm considering this, when and how should I talk to my surgeon or doctor?

This conversation must happen well in advance of any scheduled surgery, ideally during the pre-operative assessment. Do not initiate any fasting protocol without explicit guidance from your surgical team. Come to the appointment prepared to discuss: 1) Your specific surgical procedure and its metabolic demands, 2) Your complete medical history (especially diabetes, kidney issues, or nutritional status), 3) All medications and supplements you take, and 4) The exact intermittent fasting protocol you are considering (e.g., 16:8, 5:2). This allows your doctor to assess potential interactions with anesthesia, medications, and your body's healing capacity. The goal is a shared decision-making process that prioritizes safety and evidence-based practice over theoretical benefits.

Expert Insight: The pre-operative clinic is the perfect venue for this discussion. As a clinician, I need to integrate a patient's interest in fasting with the non-negotiable requirements of safe anesthesia and surgical recovery. Bringing a clear plan to discuss allows me to provide specific, personalized contraindications or adjustments, rather than a generic "yes" or "no."

What does the strongest current evidence actually support regarding fasting and surgery?

The strongest and most clinically relevant evidence supports very short-term, physician-supervised fasting immediately before surgery, distinct from popular intermittent fasting patterns. This is based on research into "pre-operative carbohydrate loading" and enhanced recovery after surgery (ERAS) protocols. These strategies involve consuming clear, carbohydrate-rich drinks up to 2-3 hours before anesthesia to reduce insulin resistance and postoperative nausea, not prolonged fasting. For longer-term intermittent fasting (e.g., 16:8 daily), the robust evidence is primarily for metabolic improvements in conditions like insulin resistance and obesity in a non-surgical context. There is no high-quality evidence from randomized controlled trials demonstrating that such long-term patterns directly improve surgical outcomes like complication rates, length of stay, or wound healing compared to standard nutritional care.

Can Intermittent Fasting Enhance Surgical Outcomes? What Research Shows